Updates

Explore Medicines360’s latest news and resources

Press Releases

Medicines360 and HRA Partner to Enhance Availability of Emergency Contraceptive ella® in the U.S.

SAN FRANCISCO and MORRISTOWN, N.J.: Medicines360, a mission-driven nonprofit women’s health pharmaceutical organization, and HRA Pharma, a global consumer healthcare company, announced today that the two organizations are partnering to support U.S. publicly funded family planning clinics’ access to prescription emergency contraceptive ulipristal acetate (UPA), commonly known in the U.S. as ella®. HRA Pharma first […]

Read More >
Blog

National Women’s Health Week

Medicines360 joins individuals and communities across the country in celebration of National Women’s Health Week, the annual weeklong observance led by the U.S. Department of Health and Human Services’ Office on Women’s Health (OWH). This year’s observance, perhaps more so than any in recent history, offers the nation a timely opportunity to center women and […]

Read More >
News

Introduction Of Long-acting Family Planning Method To USAID Product Catalog

In April 2021, the levonorgestrel-releasing intrauterine device (IUD) also known as the hormonal IUD or hormonal intrauterine system (IUS) was added to the U.S. Agency for International Development (USAID)’s Product Catalog for the first time. This milestone was made possible thanks to support from the Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project, […]

Read More >
Blog

Reflecting on Our Impact and Looking to the Future

After an amazing five years of working with some of the most passionate leaders in women’s health, I have ended my time as Medicines360 CEO to embark on a new venture. As I look back on the past five years, I’m incredibility proud of the impact we’ve made at Medicines360 for women. Not a day […]

Read More >
Press Releases

New Survey Reveals Increasing Barriers for Women Seeking Birth Control and Disproportionate Impact on Women of Color

Faced with job losses and disruption from the pandemic, women find it more challenging in 2020 to access birth control, a critical aspect of women’s health San Francisco – November 18, 2020 – Medicines360, a global nonprofit women’s health pharmaceutical organization fighting to make access to medicines for all women a reality, today released the […]

Read More >
Blog

Healthcare Policies Must Work for Women, Not Against Them

Challenges to accessing healthcare are not new for women; however, in the past year, several new roadblocks have hindered women’s access. These roadblocks span the gamut from the COVID-19 pandemic to policy changes that have impacted the fabric of women’s healthcare access. Also looming are significant changes to federal and state policies that threaten to […]

Read More >

FEATURED UPDATES

News

International Women’s Day at Direct Relief International

SANTA BARBARA INDEPENDENT – Direct Relief’s Kirchmaier Volunteer Center was standing room only Friday morning, March 8, as more than 150 people gathered in honor of International Women’s Day to celebrate achievements and acknowledge remaining hurdles, including the lack of global access to affordable maternal health care. This year’s theme was “balance for better — […]

Read More >
Press Releases

Medicines360, Afaxys Partner to Expand Public Health Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg

Strategic alliance will increase engagement with U.S. public health clinics and their patients about hormonal IUDs (long-acting reversible contraceptives, or LARCs) SAN FRANCISCO and CHARLESTON, S.C. – Medicines360 and Afaxys Pharma, LLC, two mission-driven, socially conscious women’s health pharmaceutical companies, today announced their collaboration to promote Medicines360’s intrauterine system (IUS), LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg, which is […]

Read More >
News

Medicines360 Expands Access To Contraception In Africa

FORBES – Medicines360, the non-profit pharmaceutical company behind the hormonal IUD Liletta, is on a mission to increase women’s access to reproductive care around the world. This month, the female-led company announced the launch of Avibela, a hormonal IUD, in Madagascar.

Read More >